- Home
- NSA vs SUPN Comparison
NSA vs SUPN Comparison
Compare NSA & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | SUPN |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | United States |
| Employees | 1458 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | NSA | SUPN |
|---|---|---|
| Price | $42.92 | $46.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $34.38 | ★ $61.60 |
| AVG Volume (30 Days) | ★ 721.5K | 678.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $392,755,000.00 |
| Revenue This Year | N/A | $22.70 |
| Revenue Next Year | $2.39 | $19.14 |
| P/E Ratio | $56.31 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.43 | $31.16 |
| 52 Week High | $44.02 | $59.68 |
Technical Indicators
Market Signals| Indicator | NSA | SUPN |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 37.60 |
| Support Level | $40.89 | $43.67 |
| Resistance Level | $43.96 | $46.89 |
| Average True Range (ATR) | 0.84 | 1.69 |
| MACD | -0.06 | -0.34 |
| Stochastic Oscillator | 68.64 | 5.43 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.